Inflammatory demyelination and neurodegeneration in early multiple sclerosis

Arnaud Charil, Massimo Filippi

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

A number of recent magnetic resonance imaging studies have challenged the classical view of multiple sclerosis (MS) as a "two-stage" disease where an early inflammatory demyelinating phase with focal macroscopic lesions formed in the white matter (WM) of the central nervous system is followed by a late neurodegenerative phase, which is believed to be a mere consequence of repeated inflammatory insults and irreversible demyelination. These studies have consistently shown the presence of diffuse normal-appearing WM damage, marked gray matter involvement and significant cortical functional reorganization, as well as the occurrence of the neurodegenerative component of MS from the earliest clinical stages of the disease with only a partial relation to MRI markers of inflammatory demyelination. The present review argues that MS can no longer be viewed as a "two-stage" disease, which suggests that the two pathological components are dissociated in time, but rather as a "simultaneous two-component" disease, where the relative contributions of the various pathological processes of the disease to the development of "fixed" disability, their relationship and their evolution over time need to be clarified. This new view of MS should inform the development of future research protocols to define its actual physiopathology and prompt the institution of early treatment which should ideally target not only inflammatory demyelination, but also the neurodegenerative aspects of the disease, as well as promote neuroprotection and enhance reparative mechanisms and adaptive functional reorganization of the cortex.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalJournal of the Neurological Sciences
Volume259
Issue number1-2
DOIs
Publication statusPublished - Aug 15 2007

Fingerprint

Demyelinating Diseases
Multiple Sclerosis
Pathologic Processes
Neurodegenerative Diseases
Central Nervous System
Magnetic Resonance Imaging
White Matter

Keywords

  • Disease evolution
  • Early treatment
  • Inflammatory demyelination
  • Magnetic resonance imaging
  • Multiple sclerosis
  • Neurodegeneration

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Inflammatory demyelination and neurodegeneration in early multiple sclerosis. / Charil, Arnaud; Filippi, Massimo.

In: Journal of the Neurological Sciences, Vol. 259, No. 1-2, 15.08.2007, p. 7-15.

Research output: Contribution to journalArticle

@article{2cffe79c9c12436c845d6907dc209684,
title = "Inflammatory demyelination and neurodegeneration in early multiple sclerosis",
abstract = "A number of recent magnetic resonance imaging studies have challenged the classical view of multiple sclerosis (MS) as a {"}two-stage{"} disease where an early inflammatory demyelinating phase with focal macroscopic lesions formed in the white matter (WM) of the central nervous system is followed by a late neurodegenerative phase, which is believed to be a mere consequence of repeated inflammatory insults and irreversible demyelination. These studies have consistently shown the presence of diffuse normal-appearing WM damage, marked gray matter involvement and significant cortical functional reorganization, as well as the occurrence of the neurodegenerative component of MS from the earliest clinical stages of the disease with only a partial relation to MRI markers of inflammatory demyelination. The present review argues that MS can no longer be viewed as a {"}two-stage{"} disease, which suggests that the two pathological components are dissociated in time, but rather as a {"}simultaneous two-component{"} disease, where the relative contributions of the various pathological processes of the disease to the development of {"}fixed{"} disability, their relationship and their evolution over time need to be clarified. This new view of MS should inform the development of future research protocols to define its actual physiopathology and prompt the institution of early treatment which should ideally target not only inflammatory demyelination, but also the neurodegenerative aspects of the disease, as well as promote neuroprotection and enhance reparative mechanisms and adaptive functional reorganization of the cortex.",
keywords = "Disease evolution, Early treatment, Inflammatory demyelination, Magnetic resonance imaging, Multiple sclerosis, Neurodegeneration",
author = "Arnaud Charil and Massimo Filippi",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.jns.2006.08.017",
language = "English",
volume = "259",
pages = "7--15",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Inflammatory demyelination and neurodegeneration in early multiple sclerosis

AU - Charil, Arnaud

AU - Filippi, Massimo

PY - 2007/8/15

Y1 - 2007/8/15

N2 - A number of recent magnetic resonance imaging studies have challenged the classical view of multiple sclerosis (MS) as a "two-stage" disease where an early inflammatory demyelinating phase with focal macroscopic lesions formed in the white matter (WM) of the central nervous system is followed by a late neurodegenerative phase, which is believed to be a mere consequence of repeated inflammatory insults and irreversible demyelination. These studies have consistently shown the presence of diffuse normal-appearing WM damage, marked gray matter involvement and significant cortical functional reorganization, as well as the occurrence of the neurodegenerative component of MS from the earliest clinical stages of the disease with only a partial relation to MRI markers of inflammatory demyelination. The present review argues that MS can no longer be viewed as a "two-stage" disease, which suggests that the two pathological components are dissociated in time, but rather as a "simultaneous two-component" disease, where the relative contributions of the various pathological processes of the disease to the development of "fixed" disability, their relationship and their evolution over time need to be clarified. This new view of MS should inform the development of future research protocols to define its actual physiopathology and prompt the institution of early treatment which should ideally target not only inflammatory demyelination, but also the neurodegenerative aspects of the disease, as well as promote neuroprotection and enhance reparative mechanisms and adaptive functional reorganization of the cortex.

AB - A number of recent magnetic resonance imaging studies have challenged the classical view of multiple sclerosis (MS) as a "two-stage" disease where an early inflammatory demyelinating phase with focal macroscopic lesions formed in the white matter (WM) of the central nervous system is followed by a late neurodegenerative phase, which is believed to be a mere consequence of repeated inflammatory insults and irreversible demyelination. These studies have consistently shown the presence of diffuse normal-appearing WM damage, marked gray matter involvement and significant cortical functional reorganization, as well as the occurrence of the neurodegenerative component of MS from the earliest clinical stages of the disease with only a partial relation to MRI markers of inflammatory demyelination. The present review argues that MS can no longer be viewed as a "two-stage" disease, which suggests that the two pathological components are dissociated in time, but rather as a "simultaneous two-component" disease, where the relative contributions of the various pathological processes of the disease to the development of "fixed" disability, their relationship and their evolution over time need to be clarified. This new view of MS should inform the development of future research protocols to define its actual physiopathology and prompt the institution of early treatment which should ideally target not only inflammatory demyelination, but also the neurodegenerative aspects of the disease, as well as promote neuroprotection and enhance reparative mechanisms and adaptive functional reorganization of the cortex.

KW - Disease evolution

KW - Early treatment

KW - Inflammatory demyelination

KW - Magnetic resonance imaging

KW - Multiple sclerosis

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=34447092879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447092879&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2006.08.017

DO - 10.1016/j.jns.2006.08.017

M3 - Article

VL - 259

SP - 7

EP - 15

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -